Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Journal of Cell Science
|
February 10, 2023
DRP1 mutations associated with EMPF1 encephalopathy alter mitochondrial membrane potential and metabolic programs
Gabriella L Robertson, Stellan Riffle, Mira Patel, et al.
Molecular Cancer
|
May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square
|
May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Nature Cancer
|
May 11, 2023
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
Dionysios C Watson, Defne Bayik, Simon Storevik, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Journal of Cell Science
|
February 10, 2023
DRP1 mutations associated with EMPF1 encephalopathy alter mitochondrial membrane potential and metabolic programs
Gabriella L Robertson, Stellan Riffle, Mira Patel, et al.
Molecular Cancer
|
May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square
|
May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia
Shakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Nature Cancer
|
May 11, 2023
GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity
Dionysios C Watson, Defne Bayik, Simon Storevik, et al.
Page
of 5